Sharon Worcester is an award-winning medical journalist for MDedge News. She has been with the company since 1996, first as the Southeast Bureau Chief (1996-2009) when the company was known as International Medical News Group, then as a freelance writer (2010-2015) before returning as a reporter in 2015. She previously worked as a daily newspaper reporter covering health and local government. Sharon currently reports primarily on oncology and hematology. She has a BA from Eckerd College and an MA in Mass Communication/Print Journalism from the University of Florida. Connect with her via LinkedIn and follow her on twitter @SW_MedReporter.
News
Study: Immune checkpoint inhibitors don’t increase risk of death in cancer patients with COVID-19
- Author:
- Sharon Worcester
The mortality rate was 8% among patients who received immune checkpoint inhibitors, which is comparable with the overall mortality rate among...
News
Hepatitis screening now for all patients with cancer on therapy
- Author:
- Sharon Worcester
All patients with cancer who are candidates for systemic therapy should be screened for hepatitis B, says the American Society of Clinical...
News
Study finds no link between platelet count, surgery bleed risk in cirrhosis
- Author:
- Sharon Worcester
Logistic regression analysis showed no significant association between platelet count and major bleeding events.
News
Higher death rate seen in cancer patients with nosocomial COVID-19
- Author:
- Sharon Worcester
All-cause mortality was higher in cancer patients with hospital-acquired COVID-19 than in those with community-acquired COVID-19.
News
Large cohort study: Bevacizumab safe, effective for severe HHT bleeds
- Author:
- Sharon Worcester
Bevacizumab was effective for severe HHT-related epistaxis and GI bleeds, leading to "significant and striking improvements" on a variety of...
News
CCC19, other registries help define COVID/cancer landscape
- Author:
- Sharon Worcester
New data from CCC19 show an increased risk of death from COVID-19 among non-Hispanic black cancer patients and patients with hematologic...
News
SPK-8011 AAV-mediated hemophilia A therapy shows stability, durability
- Author:
- Sharon Worcester
The findings demonstrate preliminary stability of FVIII expression at follow-up between 2 and 3.3 years....
News
Liver biopsies show persistent FVIII after gene therapy for hemophilia A
- Author:
- Sharon Worcester
“This was very exciting to see ... [n]ot only were we able to detect vector genomes more than 2 years post-dose, there seems to be quite a bit of...
News
Analysis of early onset cancers suggests need for genetic testing
- Author:
- Sharon Worcester
The prevalence of germline mutations was significantly higher in patients with early onset cancers than in those with young adult cancers.
News
AI markers can predict progression, survival in prostate cancer
- Author:
- Sharon Worcester
Artificial intelligence–based Gleason scores correlated with pathologists’ Gleason scores.
News
Lipophilic statins linked to lower mortality in ovarian cancer
- Author:
- Sharon Worcester
Lipophilic statin use was associated with a 43% reduction in mortality.
News
Novel SERD, LSZ102, shows promise for pretreated ER+ breast cancer
- Author:
- Sharon Worcester
LSZ102 was relatively well tolerated as a single agent and in combination with ribociclib and alperisib.
News
Tumor markers are ‘valuable’ for relapse detection in rare CNS tumors
- Author:
- Sharon Worcester
Among evaluable patients, 92% of relapses were detectable by tumor markers.
News
Sequential chemoradiation improves DFS in early-stage cervical cancer
- Author:
- Sharon Worcester
The 3-year disease-free survival rate was significantly higher among patients who received sequential chemoradiation than among patients who...
News
Immunotherapy combo improves ORR, PFS in PD-L1+ NSCLC
- Author:
- Sharon Worcester
Adding tiragolumab to atezolizumab led to “clinically meaningful” improvements in patients with PD-L1–positive non–small cell lung cancer.